Estudo comparativo do possível efeito protetor da vitamina e na injúria pulmonar obtida por administração de doxorrubicina em ratos

Estudo comparativo do possível efeito protetor da vitamina e na injúria pulmonar obtida por administração de doxorrubicina em ratos

OBJETIVO: A doxorrubicina, um dos fármacos mais utilizados no tratamento do câncer, apresenta toxicidade cardiopulmonar acentuada, muitas vezes impedindo o tratamento completo. O tocoferol (vitamina E), por sua vez, demonstrou atenuar os efeitos cardiotóxicos provocados pela doxorrubicina, permitind...

Full description

Bibliographic Details
Main Authors:	Luiz Augusto Lopes da Costa, Vanessa Niemiec Teixeira, Airton Schneider
Format:	Article
Language:	English
Published:	Colégio Brasileiro de Cirurgiões
Series:	Revista do Colégio Brasileiro de Cirurgiões
Subjects:	Tocopherol Vitamin E Doxorubicin Adriamycin Lung Lung Injury
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-69912004000400008&lng=en&tlng=en

Similar Items

None Herbal Agents as Preventive and Therapeutic Measures for Doxorubicin Induced Hepatotoxicity: A Comprehensive Review
by: Faezeh Mahmoudi, et al.
Published: (2022-10-01)

Potential chemoprotective effects of active ingredients in Salvia miltiorrhiza on doxorubicin-induced cardiotoxicity: a systematic review of in vitro and in vivo studies
by: Qingqing Wang, et al.
Published: (2023-10-01)

Two-Mechanism Peak Concentration Model for Cellular Pharmacodynamics of Doxorubicin
by: Ardith W. El-Kareh, et al.
Published: (2005-07-01)

Attenuation of neuroinflammation reverses Adriamycin-induced cognitive impairments
by: Barrett D. Allen, et al.
Published: (2019-11-01)

Chondroitin sulfate modified and adriamycin preloaded hybrid nanoparticles for tumor‐targeted chemotherapy of lung cancer
by: Xiang Liang, et al.
Published: (2021-05-01)

Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
by: Mateusz Kciuk, et al.
Published: (2023-02-01)

Vitamin E Isoforms as Modulators of Lung Inflammation
by: Hiam Abdala-Valencia, et al.
Published: (2013-10-01)

Dysbiotic lung microbial communities of neonates from allergic mothers confer neonate responsiveness to suboptimal allergen
by: Jeffery C. Bloodworth, et al.
Published: (2023-03-01)

Assessment of the Nutraceutical Effects of Oleuropein and the Cytotoxic Effects of Adriamycin, When Administered Alone and in Combination, in MG-63 Human Osteosarcoma Cells
by: Katerina Gioti, et al.
Published: (2021-01-01)

Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin
by: Yingying Wang, et al.
Published: (2020-02-01)

Induction of programmed cell death in lung cancer cells by secondary metabolites of Nocardia carnea UTMC 863 as soil actinomycetes
by: Tohid Moradi Gardeshi, et al.
Published: (2022-08-01)

Evaluation of Flavonoid Derivative and Doxorubicin Effects in Lung Cancer Cells (A549) Using Differential Pulse Voltammetry Method
by: Mohammad Amjadi, et al.
Published: (2018-11-01)

Alterações ecocardiográficas em cães sob tratamento prolongado com doxorrubicina Echocardiografhic changes in dogs long term treated with doxorubicin
by: C.E.V. Silva, et al.
Published: (2005-06-01)

Radiotherapy-induced enrichment of EGF-modified doxorubicin nanoparticles enhances the therapeutic outcome of lung cancer
by: Jing Wang, et al.
Published: (2022-12-01)

EFFECT OF SEVOFLURANE EXPOSURE ON ADRIAMYCIN-INDUCED INJURIES TO MYOCYTES
by: Li-hua Fan, et al.
Published: (2014-01-01)

Afatinib Sensibilizes Multidrug-resistant Human Ovarian Cancer Cells to Adriamycin and Related Mechanisms
by: ZHANG Yunqi, et al.
Published: (2018-10-01)

Effects of the Combination of Gliotoxin and Adriamycin on the Adriamycin-Resistant Non-Small-Cell Lung Cancer A549 Cell Line
by: Le Van Manh Hung, et al.
Published: (2018-03-01)

Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma
by: Sami Al-Nadaf, et al.
Published: (2018-11-01)

Intramuscular Diphenhydramine Does Not Affect Acute Doxorubicin Infusion-Related Arrhythmia Number or Severity in a Prospective Crossover Study in Canine Lymphoma: A Pilot Study
by: Jennifer Lindley Willcox, et al.
Published: (2020-07-01)

Doxyl Nitroxide Spin Probes Can Modify Toxicity of Doxorubicin towards Fibroblast Cells
by: Jan Czepas, et al.
Published: (2020-11-01)

Synergistic effect of doxorubicin lauroyl hydrazone derivative delivered by α-tocopherol succinate micelles for the treatment of glioblastoma
by: Mingchao Wang, et al.
Published: (2023-12-01)

Resecciones pulmonares: Morbilidad y mortalidad
by: Carlos Romero Díaz, et al.
Published: (2001-12-01)

Evaluación de la injuria pulmonar aguda
by: Luis González Z., et al.
Published: (2019-09-01)

Fibrosis pulmonar idiopática en un ecuatoriano adulto de la provincia de Riobamba
by: Leticia Remón Ramírez, et al.

How to Simplify the Evaluation of Newly Introduced Chemotherapeutic Interventions in Myeloma
by: Treen Carson Michael Morris, et al.
Published: (2021-02-01)

Protection against Doxorubicin-Induced Cardiac Dysfunction Is Not Maintained Following Prolonged Autophagy Inhibition
by: Ryan N. Montalvo, et al.
Published: (2020-10-01)

NBDHEX re‐sensitizes adriamycin‐resistant breast cancer by inhibiting glutathione S‐transferase pi
by: Huanhuan Sha, et al.
Published: (2023-03-01)

Transdermal Delivery of Adriamycin to Transplanted Ehrlich Ascites Tumor in Mice
by: Ryoichi Matsuda, et al.
Published: (2013-07-01)

Icariin synergizes therapeutic effect of dexamethasone on adriamycin-induced nephrotic syndrome
by: Juan Lv, et al.
Published: (2023-01-01)

Different preventive effects of four cardioprotective agents on mice with adriamycin-induced cardiotoxicity
by: CHEN Yifan, SHEN Yihui, CHENG Leilei, LIN Jinyi, ZHANG Hui, WANG Xuejun, XU Yuchen, ZHANG Jian, GE Junbo
Published: (2022-10-01)

Adriamycin activity's durational governance of different cell death types and zonality in rat liver acinus. Immunohistochemical studies
by: Pedrycz Agnieszka, et al.
Published: (2014-03-01)

Adriamycin-induced fetal hydronephrosis
by: Anderson Gonçalves, et al.
Published: (2004-12-01)

Slowing down of chronic renal failure progression with captopril in spontaneously hypertensive rats with adriamycin nephropathy
by: Jovanović Dijana B., et al.
Published: (2002-01-01)

Investigation of the Therapeutic Effects of Chloroquine in Adriamycin-Induced Hepatotoxicity
by: Akin Ali Tuğrul, et al.
Published: (2021-01-01)

Lisinopril Protects Against the Adriamycin Nephropathy and Reverses the Renalase Reduction: Potential Role of Renalase in Adriamycin Nephropathy
by: Pengxun Han, et al.
Published: (2013-09-01)

Enfermedad pulmonar intersticial difusa por silicosis
by: Ignacio Fernández Granell, et al.
Published: (2024-01-01)

Doxorubicin-Conjugated Zinc Oxide Nanoparticles, Biogenically Synthesised Using a Fungus <i>Aspergillus niger</i>, Exhibit High Therapeutic Efficacy against Lung Cancer Cells
by: Prakriti Mishra, et al.
Published: (2022-04-01)

Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells
by: Amirhosein Maharati, et al.
Published: (2023-07-01)

Antagonist G-mediated targeting and cytotoxicity of liposomal doxorubicin in NCI-H82 variant small cell lung cancer
by: J.N. Moreira, et al.
Published: (2004-08-01)

Dual-responsive doxorubicin-loaded nanomicelles for enhanced cancer therapy
by: Xinyi Zhang, et al.
Published: (2020-09-01)